Role of oxygenation and vascularization in drug resistance

Cytotechnology

Volumn 27, Issue 1-3, 1998, Pages 249-256

  Mattern, Jürgen ^a   Volm, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Drug resistance; Oxygenation; Tumors; Vascularization

Indexed keywords

DRUG RESISTANCE; OXYGENATION; TUMOR VASCULARIZATION;

EID: 0032412571     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-94-017-2374-9_16     Document Type: Article

References (67)

1. Angel P and Karin M (1991) The role of jun, fos and the AP-1 complex in cell proliferation and transformation. Biochem Biophs Acta 1072: 129-157.
2. Ausserer WA, Bourrat-Floeck B, Green CJ, Laderoute KR and Sutherland RM (1994) Regulation of c-jun expression during hypoxic and low-glucose stress. Mol cell Biol 14: 5032-5042.
3. Awwad HK, El Naggar M, Mocktar N and Barsoum M (1986) Intercapillary distance measurement as an indicator of hypoxia in carcinoma of the cervix uteri. Int J Radiat Oncol Biol Phys 12: 1329-1333.
4. Barbareschi M, Weidner N, Gasparini G, Morelli L, Forti S, Eccher C, Fina P, Leonardi E, Mauri MF, Bevilacqua P and Dalla Palma P (1995) Microvessel density quantification in breast carcinomas: a comparison between human counts and computer assisted image analysis. Appl Immunohistochem 3: 75-84.
5. Bicknell R and Harris AL (1992) Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesis. Sem Cancer Biol 3: 399-407.
6. Bradley G, Juranka PF and Ling V (1988) Mechanism of multidrug resistance. Biochim Biophys Acta 948: 87-128.
7. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM and Feder J (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Cin Invest 84: 1470-1478.
8. Delides GS, Venizelos J and Revesz L (1988) Vascularization and curability of stage III and IV nasopharyngeal tumors. J Cancer Res Clin Oncol 114: 321-323.
9. Denekamp J (1993) Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy (Review). Br J Radiol 66: 181-196.
10. Dewhirst MW (1993) Angiogenesis and blood flow in solid tumors. In Teicher BA (ed) Drug resistance in oncology, (pp. 3-23) Marcel Dekker, Inc., New York.
11. Folkman J and Ingber D (1992) Inhibition of angiogenesis. Sem Cancer Biol 3: 89-96.
12. Gasparini G, Barbareschi M, Boracchi P, Verderio P, Caffo O, Meli S, Dalla Palma P, Marubini E and Bevilacqua P (1995) Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Cancer J Sci Am 1: 131-141.
13. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH and Broder GJ (1988) Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14: 831-838.
14. Höckel M, Schienger K, Mitze M, Schäffer U and Vaupel P (1996) Hypoxia and radiation response in human tumors. Sem Radiat Oncol 6: 3-9.
15. Hockel M, Vorndran B, Schienger K, Baussmann E and Knapstein PG (1993) Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol Oncol 51: 141-149.
16. Kallinowski F (1996) The role of tumor hypoxia for the development of future treatment concepts for locally advanced cancer. The Cancer Journal 9: 37-40.
17. Kallinowski F (1997) Charakterisierung des Mikromilieus maligner Tumoren - Ergebnisse an experimentellen Modellen und menschlichen Rektumkarzinomen. Inaugural dissertation (Habilitation), University of Heidelberg.
18. Kallinowski F, Zander R, Hoeckel M and Vaupel P (1990) Tumor tissue oxygenation as evaluated by computerized-pO2-histography. Int J Radiat Oncol Biol Phys 19: 953-961.
19. Kalra R, Jones AM, Kirk J, Adams GE and Stratford IJ (1993) The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in Chinese hamster lung fibroblasts and human breast cancer cells in vitro. Int J Cancer 54: 650-655.
20. Kolstad P (1968) Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand J Lab Invest (suppl) 106: MS-IS?.
21. Koomägi R, Mattern J and Volm M (1995) Up-regulation of resistance-related proteins in human lung tumors with poor vascularization. Carcinogenesis 16: 2129-2133.
22. Kuwabara K, Ogawa S, Matsumoto M, Koga S, Clauss M, Pinsky DJ, Lyn P, Leavy J, Witte L, Joseph-Silverstein J, Furie MB, Torcia G, Cozzolino F, Kamada T and Stern DM (1995) Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sei USA 92: 4606-4610.
23. Lee W, Haslinger A, Karin M and Tjian R (1987) Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature 325: 368-372.
24. Luk CK, Veinot-Drebot L, Tjan E and Tannock IF (1990) Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines. J Natl Cancer Inst 82: 684-692.
25. Lyng H, Sundfor K, Trope C and Rofstad EK (1995) Heterogeneity in pO2 and histological appearance in human cervix carcinoma. In: Tumor oxygenation, edited by Vaupel PW, Kelleher DK, Gunderoth M. Gustav Fischer Verlag, Stuttgart, pp 249-258.
26. Lyng H, Sundfor K, Trope C and Rofstad EK (1996) Oxygen tension and vascular density in human cervix carcinoma. Br J Cancer 74: 1559-1563.
27. Mattern J, Kallinowski F, Herfarth C and Volm M (1996a) Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer 67: 20-23.
28. Mattern J, Koomägi R and Volm M (1996b) Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma. Br J Cancer 73: 931-934.
29. Mattern J and Volm M (1996) Microvessel density and vascular endothelial growth factor expression in human tumors of different localization. Oncol Rep 3: 465-468.
30. Morrow CS, Cowan KH and Goldsmith ME (1989) Structure of the human genomic glutathione S-transferase-pi gene. Gene 75: 3-11.
31. Moulder JE and Rockwell S (1987) Tumor hypoxia: its impact on cancer therapy. Cancer Metast Rev 15: 313-341.
32. Murphy BJ, Eaderoute KR, Chin RJ and Sutherland RM (1994) Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells. Cancer Res 54: 5808-5810.
33. Nordsmark M, Overgaard M and Overgaard J (1996) Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41: 31-39.
34. O'Dwyer PJ, Yao KS, Ford P, Godwin AK and Clayton M (1994) Effects of hypoxia on detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells. Cancer Res 54: 3082-3087.
35. Raleigh JA, Dewhirst M W and Thrall DE (1996) Measuring tumor hypoxia. Sem Radiat Oncol 6: 37-45.
36. Revesz E, Siracka E, Siracka J, Delides G and Pavlaki K (1989) Variation of vascular density within and between tumors of the uterine cervix and its predictive value for radiotherapy. Int J Radiat Oncol Biol Phys 16: 1161-1163.
37. Rice GC, Hoy C and Schimke RT (1986) Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci USA 83: 5978-5982.
38. Rice GC, Eing V and Schimke RT (1987) Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (adriamycin) resistance. Proc Natl Acad Sci USA 84: 9261-9264.
39. Rockwell S (1992) Use of hypoxia-directed drugs in the therapy of solid tumors. Sem Oncol 19: 29-40.
40. Sakata K, Kwok TT, Murphy BJ, Eaderoute KR, Gordon GR and Sutherland RM (1991) Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. Br J Cancer 64: 809-814.
41. Schimke RT (1984) Gene amplification in cultured cells. Cell 37: 705-713.
42. Shweiki D, Itin A, Soffer D and Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis. Nature 359: 843-845.
43. Siracka E, Revesz E, Kovac R and Siracka J (1988) Vascular density in carcinoma of the uterine cervix and its predictive value for radiotherapy. Int J Cancer 41: 819-822.
44. Stone HB, Brown JM, Phillips TE and Sutherland RM (1993) Oxygen in human tumors: correlation between methods of measurement and response to therapy. Radiat Res 136: 422-434.
45. Sutherland RM, Ausserer WA, Murphy BJ and Eaderoute KR (1996) Tumor hypoxia and heterogeneity: challenges and opportunities for the future. Sem Radiat Oncol 6: 59-70.
46. Tannock IF (1968) The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumor. Br J Cancer 22: 258-273.
47. Teicher BA (1994) Hypoxia and drug resistance. Cancer Metastasis Rev 13: 139-168.
48. Teicher BA (1995) Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxia. Hematol Oncol Clin North Am 9: 475-506.
49. Teicher BA, Eazo JS and Sartorelli AC (1981) Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 41: 73-81.
50. Valeriote F and van Putten E (1975) Proliferation-dependent cytotoxicity of anticancer agents: a review. Cancer Res 35: 2619-2630.
51. Vaupel P (1990) Oxygenation of human tumors. Strahlenther Onkol 166: 377-386.
52. Vaupel P and Höckel M (1995) Oxygenation status of human tumors: A reappraisal using computerized pO2 histography. In Vaupel PW, Kelleher DK and Günderoth M (eds) Tumor oxygenation (pp. 219-232) Gustav Fischer Verlag, Stuttgart.
53. Vaupel P, Kallinowski F and Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465.
54. Volm M (1993) P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas. Anticancer Res 13: 375-378.
55. Volm M, Efferth T, Mattern J and Wodrich W (1992) Overexpression of c-fos and c-erbBl encoded proteins in squamous cell carcinomas of the lung of smokers. Int J Oncol 1: 69-72.
56. Volm M, Kastei M, Mattern J and Efferth T (1993) Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their relationship to proto-oncogene products in renal cell carcinomas. Cancer 71: 3981-3987.
57. Volm M, Koomägi R and Mattern J (1996) Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma. Anticancer Res 16:213-217.
58. Volm M, Mattern J and Samsel B (1991) Overexpression of P-glycoprotein and glutathione S-transferase-pi in resistant nonsmall cell lung carcinomas of smokers. Br J Cancer 64: 700-704.
59. Wang Y, Teicher BA, Shea TC, Holden SA, Rosbe KW, Al-Achi A and Henner WD (1989) Cross-resistance and glutathione S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Cancer Res 49: 6185-6192.
60. Wardman P, Clarke ED, Hodgkiss RJ, Middleton RW, Parrick J and Stratford MRL (1984) Nitroaryl compounds as potential fluorescent probes for hypoxia. I. Chemical criteria and constraints. Int J Radiat Oncol 10: 1347-1351.
61. Weidner N (1993) Tumor angiogenesis: review of current applications in tumor prognostication. Sem Diagn Pathol 10: 302-313.
62. Weidner N (1995) Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36: 169-180.
63. Weidner N, Semple JP, Welch WR and Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8.
64. Wike-Hooley JL, Havemann J and Reinhold HS (1984) The relevance of tumor pH to the treatment of malignant disease. Radiother Oncol 2: 343-366.
65. Wilson RE, Keng PC and Sutherland RM (1989) Drug resistance in Chinese hamster ovary cells during recovery from severe hypoxia. J Natl Cancer Inst 81: 1235-1240.
66. Wilson RE and Sutherland RM (1989) Enhanced synthesis of specific proteins, RNA, and DNA caused by hypoxia and reoxygenation. Int J Radiat Oncol Biol Phys 16: 957-961.
67. Yao KS, Xanthoudakis S, Curran T and O'Dwyer PJ (1994) Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol cell Biol 14: 5997-6003.